Preclinical characterization of CNS-active, mutant-selective fourth-generation EGFR inhibitors with potent activity against single, double, and triple mutant EGFR variants including T790M and C797S

Subjects

Subjects :

Cancer Research
Oncology

Details

ISSN :

09598049

Volume :

174

Database :

OpenAIRE

Journal :

European Journal of Cancer

Accession number :

edsair.doi...........8e4d09586a5c5ff6d9644ff6047e4b14

Full Text :

https://doi.org/10.1016/s0959-8049(22)01024-3